TP53 and neoplasm: ICIs induce upregulation of IFN-γ in the TME, activating the JAK-STAT pathway and enhancing IRF-8 expression, which binds to the MDM2 promoter to induce MDM2 expression, ultimately suppressing p53 activity and accelerating tumor progression (37).